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Abstract 26 
 27 
Glycolytic and pentose phosphate pathway (PPP) activities were modulated in porcine 28 
cumulus-oocyte complexes (COCs) during in vitro maturation (IVM) by the addition of 29 
inhibitors or stimulators of key enzymes of the pathways in order to elucidate their 30 
relative participation in oocyte maturation. The activities of glycolysis and PPP were 31 
evaluated by lactate production per COC and by the Brilliant Cresyl Blue (BCB) test, 32 
respectively. Glucose uptake per COC and the oocyte maturation rate were also 33 
evaluated. Lactate production, glucose uptake and the percentage of oocytes reaching 34 
metaphase II decreased in a dose-dependent manner in the presence of the 35 
pharmacological (NaF) or the physiological (ATP) inhibitors of glycolysis (P<0.05). 36 
The addition of the physiological stimulator of glycolysis (AMP) caused no effect on 37 
lactate production, glucose uptake or the meiotic maturation rate. The pharmacological 38 
(6-AN) and the physiological (NADPH) inhibitors of PPP induced a dose-dependent 39 
decrease in the percentage of oocytes with high PPP activity and in the nuclear 40 
maturation rate (P<0.05). The physiological stimulator of PPP (NADP) caused no effect 41 
on the percentage of oocytes with high PPP activity. The glycolytic and PPP activities 42 
of porcine COCs and maturational competence of oocytes seem to be closely related 43 
events. This study shows for the first time the regulatory effect of ATP and NADPH as 44 
physiological inhibitors of glycolysis and PPP in porcine COCs, respectively. Besides, 45 
these pathways seem to reach their maximum activities in porcine COCs during IVM 46 
because no further increases were achieved by the presence of AMP or NADP. 47 
 48 
Key words: Glycolysis, pentose phosphate pathway, COCs, oocyte, porcine 49 
 50 
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Introduction 51 
  52 
The oocyte and the surrounding cumulus cells are structurally and 53 
physiologically coupled. Cumulus-oocyte complexes (COCs) can consume different 54 
substrates from the ovarian follicular fluid during in vivo maturation and from culture 55 
media during in vitro maturation (IVM), to be fated towards diverse metabolic pathways 56 
involved in the maturation process (Sutton et al. 2003b; Thompson 2006). 57 
A close relationship between the presence of glucose in the maturation medium 58 
and the progression of meiosis has been observed in mouse oocytes (Downs 1995). 59 
Similarly, an adequate glucose concentration in the maturation medium improves the 60 
bovine oocyte IVM and the subsequent embryo development (Lim et al. 1999; Khurana 61 
and Niemann 2000). In the porcine species, the addition of glucose to the maturation 62 
medium accelerates the meiotic progression of oocytes (Sato et al. 2007) and increases 63 
the percentage of oocytes reaching the metaphase II nuclear stage (Wongsrikeao et al. 64 
2006a; Funahashi et al. 2008). Additionally, glucose metabolism is important in oocyte 65 
cytoplasmic maturation, which in turn is necessary for embryo development (Krisher et 66 
al. 2007). 67 
The glycolytic pathway has been proposed as the main fate for the glucose 68 
consumed by murine, bovine and porcine COCs (Downs and Utecht 1999; Cetica et al. 69 
2002; Preis et al. 2005; Krisher et al. 2007; Alvarez et al. 2012). Evidence suggests that 70 
cumulus cells metabolize glucose, producing glycolytic metabolites, mainly lactate, 71 
used by the oocyte during maturation (Cetica et al. 1999; Sutton et al. 2003a; Alvarez et 72 
al. 2012). In somatic cells, the modulation of the glycolytic pathway is thought to take 73 
place in the enzyme phosphofructokinase 1, being AMP and ATP the allosteric 74 
stimulator and inhibitor, respectively (Schirmer and Evans 1990; Nelson and Cox 75 
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2005). Additionally, this pathway is inhibited by several pharmacological compounds, 76 
such as sodium fluoride (NaF), which is widely used to inhibit glycolytic activity 77 
(Mayes and Bender 2004). 78 
Glucose can be alternatively oxidized through the pentose phosphate pathway 79 
(PPP), which appears to be linked to the regulation of oocyte maturation (Downs and 80 
Utecht 1999; Funahashi et al. 2008). The PPP has several working alternatives 81 
according to specific cell requirements: the metabolites obtained can be either used in 82 
other pathways (e.g. synthesis of nucleotides, glycolysis) or recycled in the PPP. The 83 
PPP activity is dependent on the intracellular concentrations of NADP and NADPH, 84 
which modulate the pathway positively and negatively, respectively, acting mainly on 85 
the enzyme glucose 6-phosphate dehydrogenase (Nelson and Cox 2005). Additionally, 86 
this enzyme can be inhibited pharmacologically by 6-aminonicotinamide (6-AN) 87 
(Hothersall et al. 1981). 88 
The glucose consumed by porcine COCs seems to be oxidized mainly through 89 
the glycolytic pathway and the PPP. The modulation of these pathways through the 90 
regulation of the activity of key enzymes by different compounds may thus allow us to 91 
establish their relative participation in the porcine oocyte in vitro maturation process. 92 
The effects of the addition of enzymatic inhibitors (NaF, ATP) and a stimulator (AMP) 93 
of phosphofructokinase 1 glycolysis as well as of enzymatic inhibitors (6-AN, NADPH) 94 
and a stimulator (NADP) of glucose 6-phosphate dehydrogenase PPP in IVM medium 95 
on the activities of glycolysis glycolytic activity (evaluated by lactate production) and 96 
PPP activity (evaluated by BCB test) in porcine COCs, glucose uptake per COC and 97 
oocyte maturation were analyzed. 98 
 99 
Materials and Methods 100 
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 101 
Materials 102 
 103 
Unless otherwise specified, all chemicals used were from Sigma Chemical 104 
Company (St. Louis, MO, USA). 105 
 106 
Recovery and classification of cumulus-oocyte complexes 107 
 108 
Ovaries from slaughtered gilts were transported in a warm environment (28-109 
33ºC) for the 2-3 h journey to the laboratory. Ovaries were washed in 0.9% (w/v) NaCl 110 
containing 100 000 IU/L penicillin and 100 mg/L streptomycin. COCs were aspirated 111 
from 3-8 mm antral follicles by using a 10 mL syringe and an 18-gauge needle, and 112 
oocytes surrounded by a dense cumulus were selected for in vitro culture. 113 
 114 
Oocyte in vitro maturation 115 
 116 
COCs were individually cultured in medium 199 (Earle’s salts, L-glutamine, 2.2 117 
mg/L sodium bicarbonate; GIBCO, Grand Island, NY, USA) supplemented with 10% 118 
(v/v) foetal bovine serum (GIBCO), 0.57 mM cysteine, 50 mg/L gentamicin sulphate, 119 
and 0.5 mg/L porcine follicle-stimulating hormone (FSH) (Folltropin-V, Bioniche, 120 
Belleville, Ontario, Canada) plus 0.5 mg/L porcine luteinizing hormone (LH) (Lutropin-121 
V, Bioniche) (control medium) under mineral oil at 39ºC for 48 h in a 5% CO2 122 
atmosphere (Abeydeera et al. 2001).  123 
Different regulators of glycolysis and PPP were added to the control medium: 124 
2.5 mM, 5 mM, 7.5 mM and 10 mM NaF (glycolytic pharmacological inhibitor); 1 mM, 125 
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10 mM, 20 mM and 40 mM ATP (glycolytic physiological inhibitor); 1 mM, 10 mM, 126 
20 mM and 40 mM AMP (glycolytic physiological stimulator); 0.01 mM, 0.025 mM, 127 
0.05 mM and 0.1 mM 6-AN (PPP pharmacological inhibitor); 0.0125 mM, 0.125 mM, 128 
1.25 mM and 12.5 mM NADPH (PPP physiological inhibitor); 0.0125 mM, 0.125 mM, 129 
1.25 mM and 12.5 mM NADP (PPP physiological stimulator). 130 
 131 
Evaluation of oocyte maturation 132 
 133 
In vitro matured oocytes were denuded by gentle pipetting after incubation in 1 134 
g/l hyaluronidase in phosphate-buffered saline (PBS) for 5 min at 37ºC, placed in a 135 
hypotonic medium of 10 g/L sodium citrate at 37ºC for 15 min, fixed on a slide with 136 
Carnoy fixing solution (3:1 ethanol:acetic acid), and stained with 5% (v/v) Giemsa 137 
(Merck, Darmstadt, Germany) for 15 min. They were then observed under the light 138 
microscope at x100 and x400 magnification. Only oocytes with condensed and well-139 
defined metaphase II chromosome configurations were considered meiotically mature 140 
(Alvarez et al. 2009). 141 
 142 
Evaluation of the viability of cumulus-oocyte complexes  143 
To evaluate viability of cumulus cells and oocytes, an aliquot of COCs from 144 
each treatment group was incubated for 10 min at 37ºC in PBS added with 2.5 µg/l 145 
fluorescein diacetate fluorochrome. Then, COCs were washed in PBS before being 146 
observed in an epifluorescence microscope (Zeiss, Germany) using a 510 nm filter at 147 
x100 magnification. Live cells were distinguished from dead ones based on their green 148 
fluorescence (Alvarez et al. 2009). 149 
 150 
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Evaluation of glycolytic activity 151 
 152 
To evaluate glycolytic activity in COCs during IVM, lactate production per 153 
COC was determined. COCs were individually matured in 20-µl droplets of culture 154 
medium, then removed from the droplets and the lactate content of the spent maturation 155 
medium was assessed. Lactate concentration was measured using a spectrophotometric 156 
assay based on the oxidation of this compound by lactate oxidase and the subsequent 157 
determination of the hydrogen peroxide formed (Barham and Trinder 1972).  158 
Additionally, glucose uptake per COC was measured in a similar manner by 159 
determining the glucose content of the spent maturation medium but using glucose 160 
oxidase (Barham and Trinder 1972; Gutnisky et al. 2007).  161 
Twenty-microlitre droplets of maturation medium without cells were included in 162 
each experiment to provide glucose and lactate reference concentrations. 163 
COCs removed from the droplets were processed as previously described to 164 
evaluate oocyte meiotic maturation.   165 
 166 
Evaluation of pentose phosphate pathway activity 167 
 168 
To evaluate PPP activity during IVM in COCs, the Brilliant Cresyl Blue (BCB) 169 
test for immature oocytes was performed (Wongsrikeao et al. 2006b) with some 170 
modifications to be adapted to the porcine oocyte IVM. COCs were individually 171 
matured in 20-µl droplets of culture medium for 45 hours and then transferred for the 172 
last 3 hours of IVM to the same culture medium which had been added with 4.8 µM of 173 
BCB. Oocytes were denuded as previously described and finally separated into two 174 
different groups according to their cytoplasmic colouration: BCB-positive oocytes (with 175 
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blue cytoplasmic colouration) indicate a low activity of PPP, whereas BCB-negative 176 
oocytes (with no blue cytoplasmic colouration) indicate a high activity of PPP.  177 
Additionally, lactate production and glucose uptake per COC were determined 178 
by assessing lactate and glucose contents of the spent maturation medium, as described 179 
above. 180 
COCs removed from the droplets were processed as previously described to 181 
evaluate oocyte meiotic maturation. 182 
 183 
Statistical analysis and experimental design 184 
 185 
Non-parametric values were recorded as percentages and analysed using a Chi-186 
squared test. Parametric values were reported as means ± SEM and comparisons were 187 
made by ANOVA. The Pearson test was used to determine the correlation between 188 
glucose uptake and lactate production per COC. Significance was set at P<0.05. 189 
 190 
Results  191 
 192 
Effect of NaF on glycolytic activity 193 
 194 
Lactate, an end product of glycolysis, was measured in IVM medium to assess 195 
the activity of glycolysis in porcine COCs in the presence of different concentrations of 196 
the pharmacological inhibitor of the pathway. Lactate production per COC disclosed a 197 
dose-dependent decrease in the presence of NaF (P<0.05, Figure 1a). Glucose uptake 198 
per COC showed a similar behaviour in the presence of this compound in IVM medium 199 
(P<0.05, Figure 1b). A very high positive correlation between glucose uptake and 200 
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lactate production was observed (r=0.86; P=0.0000). The oocyte meiotic maturation rate 201 
decreased from 5 mM NaF onward (P<0.05, Figure 1c). However, cumulus cells and 202 
oocyte viability were not affected at any of the concentrations of NaF evaluated (Table 203 
1). 204 
 205 
Effect of ATP on glycolytic activity 206 
 207 
As observed with NaF, both lactate production and glucose uptake per COC 208 
decreased in a dose-dependent manner in the presence of the physiological inhibitor of 209 
the glycolytic pathway (P<0.05, Figure 2a and 2b). Again, a very high positive 210 
correlation between glucose uptake and lactate production was observed (r=0.86; 211 
P=0.0000). The oocyte meiotic maturation rate also showed a dose-dependent decrease 212 
in the presence of ATP (Figure 2c). However, neither cumulus cells nor oocyte viability 213 
were affected at any of the concentrations of ATP used (Table 1). 214 
 215 
Effect of AMP on glycolytic activity 216 
 217 
There was no difference in lactate production or glucose uptake per COC in the 218 
presence of increasing concentrations of the physiological stimulator of glycolysis 219 
(Figure 3a and 3b). A very strong positive correlation between glucose uptake and 220 
lactate production was observed (r=0.87; P=0.0000). The oocyte meiotic maturation rate 221 
did not show variation in the presence of AMP (Figure 3c). Neither cumulus cells nor 222 
oocyte viability were affected at any of the concentrations of AMP assessed (Table 1).  223 
 224 
Effect of 6-AN on pentose phosphate pathway activity 225 
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 226 
The BCB test was used to evaluate the activity of PPP in porcine COCs in the 227 
presence of different concentrations of the pharmacological inhibitor of the metabolic 228 
pathway. The results showed a dose-dependent decrease in the percentage of oocytes 229 
with high PPP activity of with the addition of 6-AN in IVM medium (P<0.05, Figure 230 
4a). Both lactate production and glucose uptake per COC decreased to a plateau from 231 
0.025 to 0.1 mM 6-AN, not showing a dose-dependent effect (P<0.05; Figure 4b and 232 
4c). A good positive correlation between glucose uptake and lactate production was 233 
observed (r=0.63; P=0.0000). The oocyte meiotic maturation rate decreased in a dose-234 
dependent manner in the presence of the pharmacological inhibitor of PPP (Figure 4d). 235 
However, neither cumulus cells nor oocyte viability were affected at any of the 236 
concentrations of 6-AN studied (Table 1). 237 
 238 
Effect of NADPH on pentose phosphate pathway activity 239 
 240 
As observed with 6-AN, there was a dose-dependent decrease in both the 241 
percentage of oocytes with high PPP activity of and the meiotic maturation rate in the 242 
presence of the physiological inhibitor of the pathway (P<0.05, Figure 5a and 5d). 243 
However, lactate production and glucose uptake per COC remained constant in the 244 
presence of the different concentrations of NADPH (Figure 5b and 5c). A high positive 245 
correlation between glucose uptake and lactate production was recorded (r=0.72; 246 
P=0.0000). Neither cumulus cells nor oocyte viability were affected at any of the 247 
concentrations of NADPH evaluated (Table 1). 248 
 249 
Effect of NADP on pentose phosphate pathway activity 250 
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 251 
The addition of increasing concentrations of the physiological stimulator of PPP 252 
showed no effect on the activity of the pathway (Figure 6a). Lactate production per 253 
COC decreased to a plateau from 0.125 to 12.5 mM NADP (P<0.05, Figure 6b), 254 
although glucose uptake was not modified respect to control (Figure 6c). A weak 255 
positive correlation between glucose uptake and lactate production was determined 256 
(r=0.31; P=0.0019). A slightly but significant decrease in the oocyte meiotic maturation 257 
rate was observed in the presence of NADP (P<0.05, Figure 6d). However, neither 258 
cumulus cells nor oocyte viability were affected at any of the concentrations of NADP 259 
assessed (Table 1). 260 
 261 
Discussion 262 
 263 
The glucose consumption by COCs during in vitro culture is necessary for 264 
proper oocyte maturation (Thompson 2006). The fate of glucose towards glycolysis and 265 
PPP could be directly implicated in the acquisition of maturational competence. Here, 266 
the modulation of the glycolytic and PPP activities by means of enzymatic effectors 267 
demonstrated the impact of these metabolic pathways on the progression of oocyte 268 
maturation, increasing the understanding of the participation of each pathway in the 269 
maturation process. 270 
The glucose consumed by porcine COCs would mainly be converted to lactate, 271 
suggesting significant glycolytic activity by cumulus cells (Alvarez et al. 2012). NaF is 272 
a well-characterized pharmacological inhibitor of glycolysis in somatic cells, and its 273 
action has been described on the enzyme enolase (Harris 2002). Lactate production and 274 
glucose uptake per COC decreased in a dose-dependent manner when porcine oocyte 275 
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IVM took place in the presence of NaF. Noteworthy, the very strong positive correlation 276 
between both parameters remained despite the addition of different concentrations of 277 
this inhibitor, demonstrating that glycolysis is the main fate of glucose consumed by 278 
porcine COCs. The concentrations of NaF found to have inhibitory effect in the present 279 
study were higher than those reported to diminish glucose consumption in several types 280 
of eukaryotic cells (Anderson 1969; Feig et al. 1971; Shayiq and Kidwai 1986), 281 
confirming the high glycolytic activity in porcine COCs. Interestingly, when maturation 282 
medium was added with 5 mM NaF, the percentage of oocytes reaching metaphase II, 283 
as well as lactate production and glucose uptake per COC, were 75% lower than those 284 
of the control group, suggesting that oocyte nuclear maturation and glycolytic activity in 285 
COCs are very closely related events in porcine species. Interestingly, when maturation 286 
medium was added with 5 mM NaF, the percentage of oocytes reaching metaphase II 287 
was 75% lower than that of the control group was a quarter than control group, and 288 
lactate production and glucose uptake per COC also showed a quarter of the activity 289 
than control groups, suggesting that oocyte nuclear maturation and glycolytic activity in 290 
COCs are very close related events in porcine species. In porcine COCs matured in 291 
medium added with other glycolytic pharmacological inhibitors, cumulus cells were 292 
removed at the conclusion of IVM and no effect on glycolytic activity was determined 293 
in denuded porcine oocytes (Herrick et al. 2006). This result is in agreement with the 294 
suggestion that glycolysis is a predominant pathway in porcine cumulus cells (Alvarez 295 
et al. 2012). The concentrations of NaF found to have inhibitory effect in the present 296 
study were higher than those reported to diminish glucose consumption in several types 297 
of eukaryotic cells (Anderson 1969; Feig et al. 1971; Shayiq and Kidwai 1986), 298 
confirming the high glycolytic activity in porcine COCs. The inhibition of oocyte 299 
maturation due to stimulation of adenylate cyclase by NaF has been reported in bovine 300 
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COCs. However, the concentration used to obtain this effect was higher than in the 301 
present study (Sirard 1990) or was utilized in combination with 3-isobutyl-1-302 
methylxanthine to achieve the inhibition of nuclear maturation (Bilodeau et al. 1993). 303 
ATP has been pointed out as a physiological regulator of glycolysis, being a 304 
negative allosteric effector of the main key enzyme of the pathway (Harris 2002; Kamp 305 
et al. 2007). Lactate production and glucose uptake per COC also showed a dose-306 
dependent decrease when porcine oocyte IVM was carried out with the addition of ATP 307 
to the maturation medium, and the very high positive correlation between both 308 
parameters remained despite the diverse concentrations of the inhibitor assessed. These 309 
results showed for the first time the regulatory effect of ATP on the glycolytic activity 310 
of porcine COCs and reinforce the statement that glycolysis is the principal metabolic 311 
route in these complexes. It is interesting to note that the inhibitory concentrations of 312 
ATP determined in this work were about the ones reported to be effective on enzymatic 313 
extracts of phosphofructokinase 1 (Harris 2002; Kamp et al. 2007). In the present work, 314 
when porcine COCs were cultured in the presence of 1 mM ATP, the oocyte nuclear 315 
nuclear maturation rate, as well as the lactate production and glucose uptake per COC, 316 
was 50% lower than that observed in the control group, confirming the close 317 
relationship between oocyte meiotic maturation and glycolytic activity in porcine COCs 318 
during IVM.  319 
The AMP has been identified as a positive allosteric effector of the main key 320 
enzyme  of glycolysis (Harris 2002; Simpfendorfer et al. 2006; Kamp et al. 2007). In 321 
the experiment performed in the presence AMP in culture medium, no effect was 322 
observed on lactate production and glucose uptake per COC, suggesting no stimulating 323 
effect by this compound on glycolysis in porcine COCs. In a previous work, we 324 
demonstrated the stimulation of glycolysis in COCs by the supplementation of IVM 325 
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medium with gonadotropins in this species (Alvarez et al. 2012). We can propose that 326 
AMP has no effect on glycolytic activity of porcine COCs or that the stimulatory effect 327 
of gonadotropins on glycolysis could overlap the effect of AMP. It is important to 328 
remark that the concentrations of AMP evaluated in this study were either the same as 329 
or higher than the ones reported previously to be effective for stimulating 330 
phosphofructokinase 1 (Simpfendorfer et al. 2006; Kamp et al. 2007). 331 
6-AN is an effective pharmacological inhibitor of the PPP, acting as a 332 
competitive inhibitor of the enzyme glucose 6-phosphate dehydrogenase (Tyson et al. 333 
2000). The addition of this compound in the IVM medium of porcine oocytes induced a 334 
dose-dependent decrease in both the percentage of oocytes with high PPP activity and 335 
the nuclear maturation rate, indicating an association between both events.  The 336 
interference of 6-AN on the meiotic progression of murine and porcine oocytes has been 337 
previously reported (Downs et al. 1998; Sato et al. 2007; Funahashi et al. 2008). 338 
Glucose uptake and lactate production per COC were inhibited at higher concentrations 339 
of 6-AN, but not in a dose-dependent manner, showing a good correlation between 340 
them. The specific inhibition of the PPP by 6-AN seems to reduce the amount of 341 
glucose used by COCs through this pathway, but the concurrent decrease in lactate 342 
production suggests a reduction in glycolytic activity as well. This effect could be 343 
explained by some kind of enzymatic inhibition of glycolysis or by the decrease in PPP 344 
end products fated to the glycolytic pathway. In coincidence, PPP inhibition also 345 
induces a decrease in glucose uptake and lactate production in murine COCs (Downs et 346 
al. 1998). This effect on glycolysis due to the inhibition of the PPP with 347 
diphenyleneiodonium has also been reported in mature porcine oocytes isolated from 348 
cumulus cells (Herrick et al. 2006). The accumulation of 6-phosphogluconate due to the 349 
inhibition of the PPP enzyme 6-phosphogluconate dehydrogenase with 6-AN has been 350 
Page 14 of 38
RDA Manuscript Proof
RDA Manuscript Proof
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 15
previously observed in somatic cells; this compound seems to inhibit the glycolytic 351 
enzyme phosphoglucose isomerase (Tyson et al. 2000). Thus, the inhibition of PPP with 352 
6-AN would lead to a secondary inhibition of glycolysis in COCs, both affecting the 353 
maturational capability of porcine oocytes. 354 
PPP activity is physiologically regulated by the intracellular NADP/NADPH 355 
ratio:  a high ratio increases glucose consumption through the pathway, whereas a low 356 
ratio induces the inhibition of the pathway (Clarenburg 1992; Nelson and Cox 2005). In 357 
the present work, the addition of NADPH in the IVM medium caused a dose-dependent 358 
decrease in both the percentage of oocytes with high PPP activity and the nuclear 359 
maturation rate, reinforcing the evidences that both events are related. These results also 360 
show for the first time the regulatory effect of NADPH on PPP activity of porcine 361 
COCs. In contrast to that observed with 6-AN, neither glucose uptake nor lactate 362 
production per COC were altered by the addition of NADPH to the maturation medium, 363 
and a high positive correlation between both parameters was maintained. Therefore, we 364 
can propose that the decrease in PPP activity by increasing levels of its physiological 365 
inhibitor would not impair the glycolytic activity in porcine COCs during IVM, in 366 
contrast to that observed with the pharmacological inhibitors of the pathway. 367 
The addition of NADP, a physiological stimulator of PPP, in the IVM medium 368 
caused no effects on the percentage of oocytes with high activity of this metabolic route. 369 
PPP activity seems to be high during porcine oocyte maturation and NADP 370 
supplementation seems to be unable to further stimulate this pathway. NADP did not 371 
modify glucose uptake per COC, although at higher concentrations it induced a 372 
reduction in lactate production by porcine COCs during IVM. The decrease observed in 373 
lactate production suggests some variation in glucose fate when NADP was present. A 374 
possible explanation is that NADP induces most of the consumed glucose to be destined 375 
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to PPP, and thus fewer molecules would be catabolised in glycolysis. This reduced 376 
glycolytic activity in COCs could justify the decrease in the number of porcine oocytes 377 
that reached metaphase II stage. Important interrelationships between different 378 
carbohydrate pathways in COCs during IVM have been described, and the over or 379 
under activation of one of them can impact on the activity of the others and 380 
subsequently affect oocyte maturational and/or developmental competence (Thompson 381 
2006).      382 
Finally, the viability of cumulus cells and oocytes was not affected at any of the 383 
concentrations of the different modulators used to control glycolytic and PPP activities, 384 
denoting that no toxic effect could be attributed to the results obtained. 385 
In conclusion, the inhibition of glycolysis or PPP during IVM of porcine COCs 386 
leads to a decrease in nuclear oocyte in vitro maturation, demonstrating the importance 387 
of glucose utilization through these pathways for the progression of meiosis in the 388 
porcine gamete. This study shows for the first time that ATP and NADPH would act as 389 
physiological negative regulators of glycolytic and PPP activities in porcine COCs, 390 
respectively. Besides, glycolysis and PPP seem to reach their maximum activities in 391 
porcine COCs under the IVM conditions used in the present study because no further 392 
increase was achieved by AMP or NADP. The modulation of alternative pathways 393 
involved in glucose metabolism and their relationship with oocyte maturation will 394 
further contribute to the elucidation of the role of this hexose in the IVM process.     395 
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Figure legends 414 
 415 
Figure 1. 416 
a. Lactate production by cumulus-oocyte complex (COC) during maturation with 417 
different concentrations of NaF. 
a, b, c
 Different superscripts over bars indicate 418 
significant differences (P<0.05). n = 30 COCs for each bar. Experiments were repeated 419 
three times. Data are presented as mean ± SEM. 420 
b. Glucose uptake by COC during maturation with different concentrations of NaF. 
a, b, c
 421 
Different superscripts over bars indicate significant differences (P<0.05). n = 30 COCs 422 
for each bar. Experiments were repeated three times. Data are presented as mean ± 423 
SEM. 424 
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c. Percentage of oocytes reaching metaphase II (M II) after maturation with different 425 
concentrations of NaF. 
a, b, c
 Different superscripts over bars indicate significant 426 
differences (P<0.05). n = 27-30 oocytes for each bar. Experiments were repeated three 427 
times. 428 
 429 
Figure 2. 430 
a. Lactate production by cumulus-oocyte complex (COC) during maturation with 431 
different concentrations of ATP. 
a, b, c, d
 Different superscripts over bars indicate 432 
significant differences (P<0.05). n = 30 COCs for each bar. Experiments were repeated 433 
three times. Data are presented as mean ± SEM. 434 
b. Glucose uptake by COC during maturation with different concentrations of ATP. 
a, b, c
 435 
Different superscripts over bars indicate significant differences (P<0.05). n = 30 COCs 436 
for each bar. Experiments were repeated three times. Data are presented as mean ± 437 
SEM. 438 
c. Percentage of oocytes reaching metaphase II (M II) after maturation with different 439 
concentrations of ATP. 
a, b, c
 Different superscripts over bars indicate significant 440 
differences (P<0.05). n = 29-30 oocytes for each bar. Experiments were repeated three 441 
times. 442 
 443 
Figure 3. 444 
a. Lactate production by cumulus-oocyte complex (COC) during maturation with 445 
different concentrations of AMP. 
a
 The same superscript over bars indicates no 446 
significant difference. n = 30 COCs for each bar. Experiments were repeated three 447 
times. Data are presented as mean ± SEM. 448 
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b. Glucose uptake by COC during maturation with different concentrations of AMP. 
a
 449 
The same superscript over bars indicates no significant difference. n = 30 COCs for 450 
each bar. Experiments were repeated three times. Data are presented as mean ± SEM. 451 
c. Percentage of oocytes reaching metaphase II (M II) after maturation with different 452 
concentrations of AMP. 
a
 The same superscript over bars indicates no significant 453 
difference. n = 29-30 oocytes for each bar. Experiments were repeated three times. 454 
 455 
Figure 4. 456 
a. Percentage of oocytes with active pentose phosphate pathway, evaluated by BCB test, 457 
after maturation with different concentrations of 6-AN. 
a, b, c, d
 Different superscripts 458 
over bars indicate significant differences (P<0.05). n = 28-30 oocytes for each bar. 459 
Experiments were repeated three times. 460 
b. Lactate production by cumulus-oocyte complex (COC) during maturation with 461 
different concentrations of 6-AN. 
a, b
 Different superscripts over bars indicate significant 462 
differences (P<0.05). n = 30 COCs for each bar. Experiments were repeated three times. 463 
Data are presented as mean ± SEM. 464 
c. Glucose uptake by COC during maturation with different concentrations of 6-AN. 
a, b
 465 
Different superscripts over bars indicate significant differences (P<0.05). n = 30 COCs 466 
for each bar. Experiments were repeated three times. Data are presented as mean ± 467 
SEM. 468 
d. Percentage of oocytes reaching metaphase II (M II) after maturation with different 469 
concentrations of 6-AN. 
a, b, c, d
 Different superscripts over bars indicate significant 470 
differences (P<0.05). n = 28-30 oocytes for each bar. Experiments were repeated three 471 
times. 472 
 473 
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Figure 5. 474 
a. Percentage of oocytes with active pentose phosphate pathway, evaluated by BCB test, 475 
after maturation with different concentrations of NADPH. 
a, b, c, d
 Different superscripts 476 
over bars indicate significant differences (P<0.05). n = 29-30 oocytes for each bar. 477 
Experiments were repeated three times. 478 
b. Lactate production by cumulus-oocyte complex (COC) during maturation with 479 
different concentrations of NADPH. 
a
 The same superscript over bars indicates no 480 
significant difference. n = 30 COCs for each bar. Experiments were repeated three 481 
times. Data are presented as mean ± SEM. 482 
c. Glucose uptake by COC during maturation with different concentrations of NADPH. 483 
a
 The same superscript over bars indicates no significant difference. n = 30 COCs for 484 
each bar. Experiments were repeated three times. Data are presented as mean ± SEM. 485 
d. Percentage of oocytes reaching metaphase II (M II) after maturation with different 486 
concentrations of NADPH. 
a, b, c, d
 Different superscripts over bars indicate significant 487 
differences (P<0.05). n = 29-30 oocytes for each bar. Experiments were repeated three 488 
times. 489 
 490 
Figure 6. 491 
a. Percentage of oocytes with active pentose phosphate pathway, evaluated by BCB test, 492 
after maturation with different concentrations of NADP. 
a
 The same superscript over 493 
bars indicates no significant difference. n = 28-30 oocytes for each bar. Experiments 494 
were repeated three times. 495 
b. Lactate production by cumulus-oocyte complex (COC) during maturation with 496 
different concentrations of NADPH. 
a, b 
Different superscripts over bars indicate 497 
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significant differences (P<0.05).  n = 30 COCs for each bar. Experiments were repeated 498 
three times. Data are presented as mean ± SEM. 499 
c. Glucose uptake by COC during maturation with different concentrations of NADP. 
a
 500 
The same superscript over bars indicates no significant difference. n = 30 COCs for 501 
each bar. Experiments were repeated three times. Data are presented as mean ± SEM. 502 
d. Percentage of oocytes reaching metaphase II (M II) after maturation with different 503 
concentrations of NADP. 
a, b, c, d
 Different superscripts over bars indicate significant 504 
differences (P<0.05). n = 28-30 oocytes for each bar. Experiments were repeated three 505 
times. 506 
 507 
Table 1. Percentage of live oocytes and live cumulus in cumulus-oocyte complex 508 
(COC) matured in the presence of different modulators. 
a
 The same superscript indicates 509 
no significant difference within line. n = 30 COCs for each value. Experiments were 510 
repeated three times. 511 
 512 
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Table 1. Effect of modulators on COC vitality 
 NaF 
0 mM 2.5 mM 5 mM 7.5 mM 10 mM 
% live oocytes 100 a 93.3 a 96.7 a 100 a 100 a 
% live cumulus 100 a 100 a 100 a 100 a 100 a 
 ATP 
0 mM 1 mM 10 mM 20 mM 40 mM 
% live oocytes 96.7 a 100 a 93.3 a 100 a 96.7 a 
% live cumulus 100 a 100 a 100 a 100 a 100 a 
 AMP 
0 mM 1 mM 10 mM 20 mM 40 mM 
% live oocytes 96.7 a 93.3 a 100 a 96.7 a 100 a 
% live cumulus 100 a 100 a 100 a 100 a 100 a 
 6-AN 
0 mM 0.01 mM 0.025 mM 0.05 mM 0.1 mM 
% live oocytes 96.7 a  a 100 a 100 100 a 93.3 a  
% live cumulus 100 a 100 a 100 a 100 a 100 a 
 NADPH 
0 mM 0.0125 mM 0.125 mM 1.25 mM 12.5 mM 
% live oocytes 100 a 100 a 100 a 96.7 a  96.7 a 
% live cumulus 100 a 100 a 100 a 100 a 100 a 
 NADP 
0 mM 0.0125 mM 0.125 mM 1.25 mM 12.5 mM 
% live oocytes 93.3 a 93.3 a 100 a 100 a 100 a 
% live cumulus 100 a 100 a 100 a 100 a 100 a 
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